2016

11/11/2016

HYMOVIS® offers a convenient two-dose regimen

Fidia Pharma USA Inc., a wholly owned subsidiary of Fidia Farmaceutici S.p.A. a worldwide leader in…
24/10/2016

Designation by the US FDA for the treatment of advanced Dupuytren’s disease

Abano Terme, October 18, 2016 - Fidia Farmaceutici announced the obtainment of Orphan Drug…
23/09/2016

A highly innovative and valuable contribution to healthcare professionals who work in contact with skin wounds

Fidia Farmaceutici SpA will take part in the 5th World Congress of the World Union of Wound Healing…
15/09/2016

Born in Italy, globally successful

Fidia Farmaceutici celebrates its 70th Anniversary - the company was born in 1946, with great…
02/08/2016

For almost 20 years, Biofarmitalia has been designing, formulating and manufacturing its own products.

Founded in 1992 to develop new technologies for cosmetic and pharmaceutical applications,…
11/05/2016

An opportunity to showcase FIDIA's unique products in the wound healing area

FIDIA Farmaceutici S.p.A., the Italian pharmaceutical company leader in hyaluronic acid (HY) - based…
24/03/2016

Fidia Farmaceutici has established a wholly owned subsidiary in Middle East, further enhancing its presence in growing markets.

Continuing its International growth, Fidia farmaceutici, a world leader in hyaluronic acid R&D and…
24/03/2016

Fidia Farmaceutici is partner in this global running event.

Fidia Farmaceutici will participate for the first time in the “Wings for Life World Run” in Milan,…
25/02/2016

Hymovis®, which is being launched in the U.S, is a highly viscoelastic hydrogel (HYADD®4) engineered using a proprietary process that increases lubrication and shock absorption properties

PARSIPPANY, N.J., February 25, 2016 – Fidia Farmaceutici S.p.A., a world leader in the research,…
25/02/2016

Fidia Farmaceutici has established a wholly owned subsidiary in Russia, further enhancing its presence in growing markets.

Fidia Pharma Russia will be instrumental in scaling up the company’s activities in the Russian…
18/01/2016

An opportunity to showcase FIDIA's unique products in the dermo-aesthetic area

FIDIA Farmaceutici S.p.A., the Italian pharmaceutical company leader in hyaluronic acid (HY) - based…

Health
Products
Website

Find out more about Fidia’s product portfolio:

Go to the website

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint healthcare
- ophthalmology
- wound care
- dermatology
- neurology
- dermo-aesthetics